You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The non-exclusive licensing and distribution deal with Evolution Labs makes PolypDx available in five states.
The agreement with PerkinElmer's Wallac Oy subsidiary will bring Mobidiag's real-time PCR-based gastrointestinal tests to a new market.
The distributors will promote Trovagene's clinical test services, and will also gain access to the research-use kits the firm is co-developing with Boreal Genomics.
Going forward, Natera said it will market its Panorama NIPT assay and carrier screening test Horizon directly to physicians.
The test screens for 90 mutations across 29 oncogenes and analyzes eight exons of three genes to help clinicians select treatments.
MedCaptain Medical Technology will distribute Magellan's blood test for diagnosing lead poisoning in children and adults within Chinese markets.
The deal marks the latest in a series of distribution agreements MDxHealth has recently signed for the SelectMDx test.
Abacus ALS will handle sales and technical support for Gyros Protein Technologies' immunoassay products in Australia and New Zealand.
The Teva Pharmaceuticals subsidiary will have exclusive rights to distribute NantHealth's comprehensive molecular cancer test in Israel.
The agreement now includes distribution of Roche's Kapa Biosystems portfolio in all geographies except the US, Brazil, and Japan.